Observational studyJournal for immunotherapy of cancer2024

EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma.

Jan H Frenking et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.